References
1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global cancer Observatory: cancer today. Lyon, France: international agency for research on cancer. 2018.
2. Sun Z, Sun X, Chen Z, Du J, Wu Y. Head and neck squamous cell carcinoma: risk factors, molecular alterations, immunology and peptide vaccines. International Journal of Peptide Research and Therapeutics. 2022;28:1-18.
3. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nature reviews cancer. 2011;11(1):9-22.
4. Zhang Q, Wang H, Zhao Q, Zhang Y, Zheng Z, Liu S, et al. Evaluation of risk factors for laryngeal squamous cell carcinoma: a single-center retrospective study. Frontiers in oncology. 2021;11:606010.
5. Almadori G, Bussu F, Paludetti G. Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification. Acta otorhinolaryngologica italica. 2006;26(6):326.
6. Mariani P, Russo D, Maisto M, Troiano G, Caponio VCA, Annunziata M, et al. Pre‐treatment neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: meta‐analysis and trial sequential analysis. Journal of Oral Pathology & Medicine. 2022;51(1):39-51.
7. Rodrigo JP, Sánchez-Canteli M, López F, Wolf GT, Hernández-Prera JC, Williams MD, et al. Tumor-infiltrating lymphocytes in the tumor microenvironment of laryngeal squamous cell carcinoma: systematic review and meta-analysis. Biomedicines. 2021;9(5):486.
8. Xu B, Salama AM, Valero C, Yuan A, Khimraj A, Saliba M, et al. The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: a comparative study. Virchows Archiv. 2021:1-10.
9. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor budding: the name is EMT. Partial EMT. Journal of clinical medicine. 2016;5(5):51.
10. Xue C, Du Y, Li Y, Xu H, Zhu Z. Tumor budding as a predictor for prognosis and therapeutic response in gastric cancer: A mini review. Frontiers in Oncology. 2023;12:1003959.
11. Voutsadakis IA. Prognostic role of tumor budding in breast cancer. World journal of experimental medicine. 2018;8(2):12.
12. Boxberg M, Kuhn P-H, Reiser M, Erb A, Steiger K, Pickhard A, et al. Tumor budding and cell nest size are highly prognostic in laryngeal and hypopharyngeal squamous cell carcinoma. The American journal of surgical pathology. 2019;43(3):303-13.
13. Kadota K, Nitadori J-i, Woo KM, Sima CS, Finley DJ, Rusch VW, et al. Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. Journal of Thoracic Oncology. 2014;9(8):1126-39.
14. Karpathiou G, Vieville M, Gavid M, Camy F, Dumollard JM, Magné N, et al. Prognostic significance of tumor budding, tumor‐stroma ratio, cell nests size, and stroma type in laryngeal and pharyngeal squamous cell carcinomas. Head & neck. 2019;41(6):1918-27.
15. Paşaoğlu HE, Emre F, Ege TŞ, Tetikkurt ÜS. High tumor budding activity may predict poor prognosis in laryngeal squamous cell carcinomas. Indian Journal of Pathology and Microbiology. 2022;65(2):280.
16. Luo L, Liu H. High-grade tumor budding is a risk factor for survival in patients with laryngeal squamous cell carcinoma. Brazilian Journal of Otorhinolaryngology. 2023:101310.
17. Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngology–Head & Neck Surgery. 2014;140(9):855-60.
18. Choi N, Kim J, Yi H, Kim H, Kim TH, Chung MJ, et al. The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma. Scientific Reports. 2023;13(1):9734.
19. Zhu X, Duan F, Zhu Y, Shi X, Sun S, Cheng Y, et al. Perineural Invasion as a Prognostic Factor in Laryngeal Squamous Cell Cancer: A Matched-Pair Survival Analysis. Cancer Investigation. 2021;39(9):734-40.
20. Contrera KJ, Hair BB, Prendes B, Reddy CA, Zimmer DI, Burkey BB, et al. Clinical versus pathologic laryngeal cancer staging and the impact of stage change on outcomes. The Laryngoscope. 2021;131(3):559-65.
21. Bhat GR, Hyole RG, Li J. Chapter Two - Head and neck cancer: Current challenges and future perspectives. In: Tew KD, Fisher PB, editors. Advances in Cancer Research. 152: Academic Press; 2021. p. 67-102.
22. Weichert W, Kossakowski C, Harms A, Schirmacher P, Muley T, Dienemann H, et al. Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma. European Respiratory Journal. 2016;47(3):938-46.
23. Leite CF, Silva KDd, Horta MCR, de Aguiar MCF. Can morphological features evaluated in oral cancer biopsies influence in decision-making? A preliminary study. Pathology - Research and Practice. 2020;216(10):153138.
24. Togni L, Caponio VCA, Zerman N, Troiano G, Zhurakivska K, Lo Muzio L, et al. The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker. Cancers. 2022;14(15):3571.
25. Chiesa-Estomba CM, Thompson L, Agaimy A, Zidar N, Simpson RHW, Franchi A, et al. Predictive value of tumor budding in head and neck squamous cell carcinoma: an update. Virchows Archiv. 2023.
26. Melanie B, Christine B, Korinna J, Peer-Hendrik K, Bernhard H, Katja S, et al. Novel prognostic histopathological grading system in oral squamous cell carcinoma based on tumour budding and cell nest size shows high interobserver and intraobserver concordance. Journal of Clinical Pathology. 2019;72(4):285.
27. Mäkitie AA, Almangush A, Rodrigo JP, Ferlito A, Leivo I. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer. Head & neck. 2019;41(10):3712-8.
28. Jesinghaus M, Boxberg M, Konukiewitz B, Slotta-Huspenina J, Schlitter AM, Steiger K, et al. A novel grading system based on tumor budding and cell nest size is a strong predictor of patient outcome in esophageal squamous cell carcinoma. The American journal of surgical pathology. 2017;41(8):1112-20.
29. Ekmekci S, Kucuk U, Kokkoz S, Cakir E, Gumussoy M. Tumor budding in laryngeal carcinoma. Indian J Pathol Microbiol. 2019;62(1):7-10.
30. Bjerkli I-H, Laurvik H, Nginamau ES, Søland TM, Costea D, Hov H, et al. Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report. PLoS One. 2020;15(9):e0239783.
31. Abd Raboh NM, Mady OM, Hakim SA. Evaluation of the potential prognostic value of tumor budding in laryngeal carcinoma by conventional and immunohistochemical staining. Analytical Cellular Pathology. 2020;2020:1-12.
32. Jesinghaus M, Strehl J, Boxberg M, Brühl F, Wenzel A, Konukiewitz B, et al. Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix. The Journal of Pathology: Clinical Research. 2018;4(2):93-102.
33. Niwa Y, Yamada S, Koike M, Kanda M, Fujii T, Nakayama G, et al. Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. Journal of surgical oncology. 2014;110(6):764-9.
34. Karjol U, Jonnada P, Annavarjula V, Cherukuru S, Chandranath A, Anwar A, et al. Prognostic role of tumor budding in carcinoma tongue: a systemic review and meta-analysis. Cureus. 2020;12(7).
35. Caruntu A, Moraru L, Lupu M, Ciubotaru DA, Dumitrescu M, Eftimie L, et al. Assessment of Histological Features in Squamous Cell Carcinoma Involving Head and Neck Skin and Mucosa. Journal of Clinical Medicine. 2021;10(11):2343.
36. D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, et al. Elective versus therapeutic neck dissection in node-negative oral cancer. New England Journal of Medicine. 2015;373(6):521-9.
37. Kirita T, Yamakawa N, Ueda N, Yagyuu T. Tumor budding as a useful prognostic indicator in early oral squamous cell carcinoma. J Cancer Sci Ther. 2018;10:162-7.
38. Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, et al. Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer. JAMA Oncol. 2018;4(7):985-9.
39. Imai T, Satoh I, Matsumoto K, Asada Y, Yamazaki T, Morita S, et al. Retrospective observational study of occult cervical lymph-node metastasis in T1N0 tongue cancer. Japanese journal of clinical oncology. 2017;47(2):130-6.
40. Imai T, Ito S, Oikawa T, Asada Y, Matsumoto K, Miyazaki T, et al. Risk factors for cervical lymph node metastasis in endoscopically resected superficial hypopharyngeal cancers. Auris Nasus Larynx. 2019;46(3):424-30.
41. Ebihara Y, Yoshida S, Nakahira M, Kogashiwa Y, Enoki Y, Kuba K, et al. Importance of tumor budding grade as independent prognostic factor for early tongue squamous cell carcinoma. Head & Neck. 2019;41(6):1809-15.
42. Li ZW, He L, Zheng Z, Zhang Q, Xu YT, Chen JY, et al. Combined assessment of tumour cell nest size and desmoplastic reaction as an excellent prognostic predictor in oesophageal squamous cell carcinoma. Histopathology. 2022;80(7):1112-20.
43. Li J, Li X, Yang J. A Novel Prognostic Stratified System Based on Tumor Budding and the Cell Nest Size in Ureter Urothelial Carcinoma. Applied Bionics and Biomechanics. 2022;2022.
44. Gkegka AG, Koukourakis MI, Katotomichelakis M, Giatromanolaki A. Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer. Head and Neck Pathology. 2023;17(2):422-32.
45. Tan A, Taskin T. Tumor Budding Should Be in Oral Cavity Cancer Reporting: A Retrospective Cohort Study Based on Tumor Microenvironment. Cancers. 2023;15(15):3905.
46. Boxberg M, Jesinghaus M, Dorfner C, Mogler C, Drecoll E, Warth A, et al. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system. Histopathology. 2017;70(7):1125-37.
47. Sarioglu S, Acara C, Akman FC, Dag N, Ecevit C, Ikiz AO, et al. Tumor budding as a prognostic marker in laryngeal carcinoma. Pathology-Research and Practice. 2010;206(2):88-92.
48. Jesinghaus M, Brühl F, Steiger K, Klare P, Reiser M, Scheiter A, et al. Cellular dissociation grading based on the parameters tumor budding and cell nest size in pretherapeutic biopsy specimens allows for prognostic patient stratification in esophageal squamous cell carcinoma independent from clinical staging. The American journal of surgical pathology. 2019;43(5):618-27.
49. Yadav K, Singh T, Varma K, Bhargava M, Misra V. Evaluation of tumor budding and its correlation with histomorphological prognostic markers in oral squamous cell carcinoma and its association with the epithelial-mesenchymal transition process. Indian Journal of Pathology and Microbiology. 2023;66(1):3.
50. Luo L, Liu H. High-grade tumor budding is a risk factor for survival in patients with laryngeal squamous cell carcinoma. Brazilian Journal of Otorhinolaryngology. 2023;89:101310.
51. Thomas B, Stedman M, Davies L. Grade as a prognostic factor in oral squamous cell carcinoma: a population‐based analysis of the data. The Laryngoscope. 2014;124(3):688-94.
52. Brandstorp-Boesen J, Sørum Falk R, Boysen M, Brøndbo K. Impact of stage, management and recurrence on survival rates in laryngeal cancer. PLoS One. 2017;12(7):e0179371.
Table 1. A summary of clinical and histopathological findings